SCHEMBL21914101

SCHEMBL21914101

CON1CCN(c2cc(F)c(C#N)c(F)c2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.39
AOC3 Q16853 1/20 0.38
KDM4E B2RXH2 2/20 0.37
TP53 P04637 1/20 0.37
DPP4 P27487 1/20 0.36
DRD2 P14416 1/20 0.36
HTR2A P28223 1/20 0.36
HRH1 P35367 1/20 0.36
MAPT P10636 6/20 0.35
ALDH1A1 P00352 3/20 0.35
RAB9A P51151 1/20 0.35
GFER P55789 1/20 0.35
LMNA P02545 2/20 0.35
HTT P42858 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HSD17B10 Q99714 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
GAA P10253 2/20 0.34
NCOA1 Q15788 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23839537 0.83 DRD2 (0.36) TRPV4AOC3KDM4ETP53DPP4
SCHEMBL17948925 0.80 TRPV4 (0.36) TRPV4AOC3DPP4
SCHEMBL8295828 0.75 DRD2 (0.51) TRPV4KDM4ETP53DRD2ALDH1A1
SCHEMBL5105409 0.75 KDM4E (0.55) TRPV4KDM4ETP53MAPTALDH1A1
SCHEMBL17948912 0.74 EGLN2 (0.46) TRPV4AOC3DPP4CHRM2CHRM5
SCHEMBL5220716 0.72 DPP4 (0.46) TRPV4KDM4EDPP4CHEK1
SCHEMBL5117647 0.72 DPP4 (0.46) TRPV4KDM4ETP53DPP4ALDH1A1
SCHEMBL5109089 0.72 MEN1 (0.49) KDM4EMAPTALDH1A1RAB9AGFER
SCHEMBL17893822 0.71 CHRM2 (0.41) AOC3KDM4EMAPTALDH1A1RAB9A
SCHEMBL14480008 0.68 LMNA (0.57) KDM4ETP53MAPTALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597364-B2 Anthelmintic compounds, compositions and method of using thereof Boehringer Ingelheim Animal Health USA Inc. (US) 2020-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10597364-B2 Anthelmintic compounds, compositions and method of using thereof CYP8B1, CYP2C8, CYP2B6 TRPV4 1659/4885AOC3 136/4885KDM4E 878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.